Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006 Nanchang, Jiangxi, China.
Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330209 Nanchang, Jiangxi, China.
Discov Med. 2024 Aug;36(187):1616-1626. doi: 10.24976/Discov.Med.202436187.148.
Idiopathic pulmonary fibrosis (IPF) is a long-term, progressive, and irreversible pulmonary interstitial disease. The activation of Smad family member 2 (Smad2) and Smad3 transcription factors by transforming growth factor β-1 (TGF-β1) is a critical event in the pathogenesis of IPF. However, there is still a lack of understanding regarding the molecular mechanisms governing Smad2 and Smad3 proteins. Ubiquitin-specific protease 7 (USP7) is a deubiquitinase that plays a vital role in regulating protein stability within cells. However, its regulation of the TGF-β signaling pathway and its significance in IPF remain undiscovered. This study aims to clarify the function of USP7 in the TGF-β signaling pathway, while simultaneously exploring the specific molecular mechanisms involved. Additionally, this study seeks to evaluate the therapeutic potential of targeted USP7 inhibitors in IPF, thereby providing novel insights for the diagnosis and management of IPF.
We first detected the expression of USP7 in lung tissues of mice with Bleomycin (BLM)-induced pulmonary fibrosis and in Beas-2B cells treated with or without TGF-β1 through Western blot analysis. Subsequently, we explored the influence of USP7 on fibrotic processes and the TGF-β1 signaling pathway, utilizing and studies. Finally, we assessed the effectiveness of USP7-specific inhibitors in an IPF murine model.
In the present study, USP7 was found to de-ubiquitinate Smad2 and Smad3, consequently increasing their stability and promoting the TGF-β1-induced production of profibrotic proteins including α-smooth muscle actin (α-SMA) and fibronectin 1 (FN-1). Inhibition or knockdown of USP7 resulted in decreased levels of Smad2 and Smad3 proteins, leading to reduced expression of FN-1, Collagen Type I Alpha 1 Chain (Col1A1), and α-SMA induced by TGF-β1 in human pulmonary epithelial cells. These findings demonstrate that overexpression of USP7 reduces Smad2/3 ubiquitination, whereas inhibition or knockdown of USP7 enhances their ubiquitination. USP7 is abundantly expressed in IPF lungs. The expressions of USP7, Smad2, and Smad3 were upregulated in bleomycin-induced lung injury. The USP7 inhibitor P22077 reduced the expression of FN-1 and type I collagen as well as Smad2/3 and collagen deposition in lung tissue in a model of pulmonary fibrosis induced by bleomycin.
This study demonstrates that USP7 promotes TGF-β1 signaling by stabilizing Smad2 and Smad3. The contribution of USP7 to the progression of IPF indicates it may be a viable treatment target.
特发性肺纤维化(IPF)是一种长期、进行性和不可逆转的肺间质疾病。转化生长因子β-1(TGF-β1)激活 Smad 家族成员 2(Smad2)和 Smad3 转录因子是 IPF 发病机制中的关键事件。然而,对于调控 Smad2 和 Smad3 蛋白的分子机制仍知之甚少。泛素特异性蛋白酶 7(USP7)是一种去泛素化酶,在细胞内蛋白质稳定性的调控中起着至关重要的作用。然而,其在 TGF-β 信号通路中的调控作用及其在 IPF 中的意义尚不清楚。本研究旨在阐明 USP7 在 TGF-β 信号通路中的功能,同时探讨其具体的分子机制。此外,本研究还评估了靶向 USP7 抑制剂在 IPF 中的治疗潜力,为 IPF 的诊断和治疗提供新的思路。
我们首先通过 Western blot 分析检测博来霉素(BLM)诱导的肺纤维化小鼠肺组织和 TGF-β1 处理的 Beas-2B 细胞中 USP7 的表达。随后,我们通过 siRNA 和过表达实验研究了 USP7 对纤维化过程和 TGF-β1 信号通路的影响。最后,我们在 IPF 小鼠模型中评估了 USP7 特异性抑制剂的疗效。
本研究发现 USP7 可去泛素化 Smad2 和 Smad3,从而增加其稳定性,促进 TGF-β1 诱导的α-平滑肌肌动蛋白(α-SMA)和纤维连接蛋白 1(FN-1)等促纤维化蛋白的产生。USP7 的抑制或敲低导致 Smad2 和 Smad3 蛋白水平降低,从而减少 TGF-β1 诱导的人肺上皮细胞中 FN-1、I 型胶原α1 链(Col1A1)和α-SMA 的表达。这些发现表明,USP7 的过表达减少了 Smad2/3 的泛素化,而抑制或敲低 USP7 则增强了它们的泛素化。USP7 在 IPF 肺组织中大量表达。USP7、Smad2 和 Smad3 的表达在博来霉素诱导的肺损伤中上调。USP7 抑制剂 P22077 可降低博来霉素诱导的肺纤维化模型中肺组织中 FN-1 和 I 型胶原以及 Smad2/3 和胶原沉积的表达。
本研究表明 USP7 通过稳定 Smad2 和 Smad3 促进 TGF-β1 信号。USP7 对 IPF 进展的贡献表明其可能是一种可行的治疗靶点。